Refine
Has Fulltext
- yes (14)
Is part of the Bibliography
- yes (14)
Document Type
- Journal article (14)
Language
- English (14)
Keywords
- ADHD (3)
- hippocampus (3)
- myelination (2)
- oxidative stress (2)
- prefrontal cortex (2)
- psychiatric disorders (2)
- 5-HT receptors (1)
- Big Five (1)
- CDH13 (1)
- CRISPR-Cas Systems (1)
- Cadherin-13 (CDH13) (1)
- GABA (1)
- GAD1 (1)
- Induced Pluripotent Stem Cells (1)
- SLC2A3 (1)
- Sert-deficient mice (1)
- Toll-like receptor 4 (TLR4) (1)
- Western diet (1)
- Xenopus laevis oocytes (1)
- aggression (1)
- aging (1)
- agreeableness (1)
- amino acid analysis (1)
- anhedonia (1)
- antioxidant nutrients (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- brain development (1)
- brain disorders (1)
- cadherins (1)
- celecoxib (1)
- cell membranes (1)
- chronic stress (1)
- citalopram (1)
- congenital heart-deffects (1)
- copy-number variation (1)
- crystal structure (1)
- depression (1)
- executive functions (1)
- extinction (1)
- fear conditioning (1)
- fear learning (1)
- female (1)
- female aggression (1)
- forced swimming (1)
- glucose (1)
- glucose tolerance (1)
- glucose transporter (1)
- glycogen synthase kinase-3 β (GSK-3β) (1)
- heterosis (1)
- heterozygote (1)
- human induced pluripotent stem cell (hiPSC) (1)
- humans (1)
- immediate-early gene (1)
- induced pluripotent stem cells (1)
- inducible cyclooxygenase-2 (COX-2) (1)
- insulin receptor (1)
- knockout (1)
- long-term potentiation (1)
- major depression (1)
- major depressive disorder (MDD) (1)
- median and dorsal raphe (1)
- membrane potential (1)
- membrane proteins (1)
- mice (1)
- middle aged (1)
- mouse (1)
- mouse model (1)
- nervous system (1)
- neurodevelopment (1)
- neurodevelopmental disorders / genetics (1)
- neuroinflammation (1)
- neuropsychiatric disorders (1)
- obesity (1)
- post-traumatic stress disorder (1)
- predation stress (1)
- pro-inflammatory cytokines (1)
- serotonin deficiency (1)
- serotonin receptors (1)
- serotonin-specific neurons (1)
- sialic acid (1)
- sialyltransferase (1)
- stress resilience (1)
- synapse formation (1)
- transporter gene SLC2A3 (1)
- tryptophan hydroxylase 2 (1)
- tryptophan hydroxylase-2 (Tph2) (1)
- working memory (1)
Institute
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (10)
- Lehrstuhl für Molekulare Psychiatrie (6)
- Institut für Humangenetik (3)
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (3)
- Physiologisches Institut (2)
- Theodor-Boveri-Institut für Biowissenschaften (2)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (1)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Institut für Anatomie und Zellbiologie (1)
- Institut für Psychologie (1)
EU-Project number / Contract (GA) number
- 728018 (14) (remove)
Copy number variants of SLC2A3, which encodes the glucose transporter GLUT3, are associated with several neuropsychiatric and cardiac diseases. Here, we report the successful reprogramming of peripheral blood mononuclear cells from two SLC2A3 duplication and two SLC2A3 deletion carriers and subsequent generation of two transgene-free iPSC clones per donor by Sendai viral transduction. All eight clones represent bona fide hiPSCs with high expression of pluripotency genes, ability to differentiate into cells of all three germ layers and normal karyotype. The generated cell lines will be helpful to enlighten the role of glucometabolic alterations in pathophysiological processes shared across organ boundaries.
The interaction between brain serotonin (5-HT) deficiency and environmental adversity may predispose females to excessive aggression. Specifically, complete inactivation of the gene encoding tryptophan hydroxylase-2 (Tph2) results in the absence of neuronal 5-HT synthesis and excessive aggressiveness in both male and female null mutant (Tph2\(^{−/−}\)) mice. In heterozygous male mice (Tph2\(^{+/−}\)), there is a moderate reduction in brain 5-HT levels, and when they are exposed to stress, they exhibit increased aggression. Here, we exposed female Tph2\(^{+/−}\) mice to a five-day rat predation stress paradigm and assessed their emotionality and social interaction/aggression-like behaviors. Tph2\(^{+/−}\) females exhibited excessive aggression and increased dominant behavior. Stressed mutants displayed altered gene expression of the 5-HT receptors Htr1a and Htr2a, glycogen synthase kinase-3 β (GSK-3β), and c-fos as well as myelination-related transcripts in the prefrontal cortex: myelin basic protein (Mbp), proteolipid protein 1 (Plp1), myelin-associated glycoprotein (Mag), and myelin oligodendrocyte glycoprotein (Mog). The expression of the plasticity markers synaptophysin (Syp) and cAMP response element binding protein (Creb), but not AMPA receptor subunit A2 (GluA2), were affected by genotype. Moreover, in a separate experiment, naïve female Tph2\(^{+/−}\) mice showed signs of enhanced stress resilience in the modified swim test with repeated swimming sessions. Taken together, the combination of a moderate reduction in brain 5-HT with environmental challenges results in behavioral changes in female mice that resemble the aggression-related behavior and resilience seen in stressed male mutants; additionally, the combination is comparable to the phenotype of null mutants lacking neuronal 5-HT. Changes in myelination-associated processes are suspected to underpin the molecular mechanisms leading to aggressive behavior.
The phenomenon of individual variability in susceptibility/resilience to stress and depression, in which the hippocampus plays a pivotal role, is attracting increasing attention. We investigated the potential role of hippocampal cyclooxygenase-2 (COX-2), which regulates plasticity, neuroimmune function, and stress responses that are all linked to this risk dichotomy. We used a four-week-long chronic mild stress (CMS) paradigm, in which mice could be stratified according to their susceptibility/resilience to anhedonia, a key feature of depression, to investigate hippocampal expression of COX-2, a marker of microglial activation Iba-1, and the proliferation marker Ki67. Rat exposure, social defeat, restraints, and tail suspension were used as stressors. We compared the effects of treatment with either the selective COX-2 inhibitor celecoxib (30 mg/kg/day) or citalopram (15 mg/kg/day). For the celecoxib and vehicle-treated mice, the Porsolt test was used. Anhedonic (susceptible) but not non-anhedonic (resilient) animals exhibited elevated COX-2 mRNA levels, increased numbers of COX-2 and Iba-1-positive cells in the dentate gyrus and the CA1 area, and decreased numbers of Ki67-positive cells in the subgranular zone of the hippocampus. Drug treatment decreased the percentage of anhedonic mice, normalized swimming activity, reduced behavioral despair, and improved conditioned fear memory. Hippocampal over-expression of COX-2 is associated with susceptibility to stress-induced anhedonia, and its pharmacological inhibition with celecoxib has antidepressant effects that are similar in size to those of citalopram.
Aggression and deficient cognitive control problems are widespread in psychiatric disorders, including major depressive disorder (MDD). These abnormalities are known to contribute significantly to the accompanying functional impairment and the global burden of disease. Progress in the development of targeted treatments of excessive aggression and accompanying symptoms has been limited, and there exists a major unmet need to develop more efficacious treatments for depressed patients. Due to the complex nature and the clinical heterogeneity of MDD and the lack of precise knowledge regarding its pathophysiology, effective management is challenging. Nonetheless, the aetiology and pathophysiology of MDD has been the subject of extensive research and there is a vast body of the latest literature that points to new mechanisms for this disorder. Here, we overview the key mechanisms, which include neuroinflammation, oxidative stress, insulin receptor signalling and abnormal myelination. We discuss the hypotheses that have been proposed to unify these processes, as many of these pathways are integrated for the neurobiology of MDD. We also describe the current translational approaches in modelling depression, including the recent advances in stress models of MDD, and emerging novel therapies, including novel approaches to management of excessive aggression, such as anti-diabetic drugs, antioxidant treatment and herbal compositions.